Diabetic Nephropathy Larry H. Bernstein, MD, FCAP, Curator LPBI   EV-077 by DR ANTHONY MELVIN CRASTO Ph.D SER150 (formerly EV-077) Also known as: formerly EV-077-3201 EV-077-3201-2TBS CAS 1384128-29-3 Evolva INNOVATOR Oral thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a small compound being developed for the treatment of complications of diabetes. In Phase 2. Outlicensed to … Continue reading Diabetic Nephropathy